Long-, intermediate- and short-acting benzodiazepine effects on human sleep EEG spectra

Xin Tan, Sunao Uchida, Masato Matsuura, Kyoko Nishihara, Takuya Kojima

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The effects of 10 mg haloxazolam (HAX), 4 mg flunitrazepam (FNZ), and 0.5 mg triazolam (TRI), each administered for seven consecutive nights were studied in the sleep electroencephalograms (EEG) of 17 (six HAX, five FNZ and six TRI) healthy male student volunteers. Recordings of C3-A1 EEG data from one baseline night, three drug nights (first, fourth and seventh) and two withdrawal nights (second and fourth) were analyzed using a fast Fourier transformation method. All three drugs induced similar changes in the 0.5 Hz to 40 Hz power spectrum; namely (i) higher frequency (including the sigma and beta bands) activity increased and lower frequency activity reduced on the drug nights; (ii) the enhancement of sigma activity peaked during non-rapid eye movement sleep following the first administration and was maintained at high levels on all drug nights; (iii) beta activity increased through the night after administration of HAX and FNZ, but not TRI, which suggests a blood concentration level dependent increase of beta activity; and (iv) only HAX showed a residual effect on the fourth withdrawal night. These results indicate that (i) chronic administration of these three benzodiazepine derivatives produce similar profiles in sleep EEG spectral changes, with some differences depending on their half-lives and doses; (ii) the mechanism of sigma enhancement is sensitive to even the initial administration night of BDZ; and (iii) frequencies below and above the sigma band are less sensitive to BDZ and also show an increase through the night after administration, suggesting differences in the mechanisms reflected by these EEG frequency bands.

Original languageEnglish
Pages (from-to)97-104
Number of pages8
JournalPsychiatry and Clinical Neurosciences
Volume57
Issue number1
DOIs
Publication statusPublished - 2003 Feb
Externally publishedYes

Fingerprint

Triazolam
Benzodiazepines
Flunitrazepam
Electroencephalography
Sleep
Pharmaceutical Preparations
Eye Movements
Volunteers
Students
haloxazolam

Keywords

  • Benzodiazepines
  • Pharmacological potency
  • Sleep electroencephalogram
  • Spectral analysis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Long-, intermediate- and short-acting benzodiazepine effects on human sleep EEG spectra. / Tan, Xin; Uchida, Sunao; Matsuura, Masato; Nishihara, Kyoko; Kojima, Takuya.

In: Psychiatry and Clinical Neurosciences, Vol. 57, No. 1, 02.2003, p. 97-104.

Research output: Contribution to journalArticle

Tan, Xin ; Uchida, Sunao ; Matsuura, Masato ; Nishihara, Kyoko ; Kojima, Takuya. / Long-, intermediate- and short-acting benzodiazepine effects on human sleep EEG spectra. In: Psychiatry and Clinical Neurosciences. 2003 ; Vol. 57, No. 1. pp. 97-104.
@article{b45d9ea7f1de446e851d1d2604907c22,
title = "Long-, intermediate- and short-acting benzodiazepine effects on human sleep EEG spectra",
abstract = "The effects of 10 mg haloxazolam (HAX), 4 mg flunitrazepam (FNZ), and 0.5 mg triazolam (TRI), each administered for seven consecutive nights were studied in the sleep electroencephalograms (EEG) of 17 (six HAX, five FNZ and six TRI) healthy male student volunteers. Recordings of C3-A1 EEG data from one baseline night, three drug nights (first, fourth and seventh) and two withdrawal nights (second and fourth) were analyzed using a fast Fourier transformation method. All three drugs induced similar changes in the 0.5 Hz to 40 Hz power spectrum; namely (i) higher frequency (including the sigma and beta bands) activity increased and lower frequency activity reduced on the drug nights; (ii) the enhancement of sigma activity peaked during non-rapid eye movement sleep following the first administration and was maintained at high levels on all drug nights; (iii) beta activity increased through the night after administration of HAX and FNZ, but not TRI, which suggests a blood concentration level dependent increase of beta activity; and (iv) only HAX showed a residual effect on the fourth withdrawal night. These results indicate that (i) chronic administration of these three benzodiazepine derivatives produce similar profiles in sleep EEG spectral changes, with some differences depending on their half-lives and doses; (ii) the mechanism of sigma enhancement is sensitive to even the initial administration night of BDZ; and (iii) frequencies below and above the sigma band are less sensitive to BDZ and also show an increase through the night after administration, suggesting differences in the mechanisms reflected by these EEG frequency bands.",
keywords = "Benzodiazepines, Pharmacological potency, Sleep electroencephalogram, Spectral analysis",
author = "Xin Tan and Sunao Uchida and Masato Matsuura and Kyoko Nishihara and Takuya Kojima",
year = "2003",
month = "2",
doi = "10.1046/j.1440-1819.2003.01085.x",
language = "English",
volume = "57",
pages = "97--104",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Long-, intermediate- and short-acting benzodiazepine effects on human sleep EEG spectra

AU - Tan, Xin

AU - Uchida, Sunao

AU - Matsuura, Masato

AU - Nishihara, Kyoko

AU - Kojima, Takuya

PY - 2003/2

Y1 - 2003/2

N2 - The effects of 10 mg haloxazolam (HAX), 4 mg flunitrazepam (FNZ), and 0.5 mg triazolam (TRI), each administered for seven consecutive nights were studied in the sleep electroencephalograms (EEG) of 17 (six HAX, five FNZ and six TRI) healthy male student volunteers. Recordings of C3-A1 EEG data from one baseline night, three drug nights (first, fourth and seventh) and two withdrawal nights (second and fourth) were analyzed using a fast Fourier transformation method. All three drugs induced similar changes in the 0.5 Hz to 40 Hz power spectrum; namely (i) higher frequency (including the sigma and beta bands) activity increased and lower frequency activity reduced on the drug nights; (ii) the enhancement of sigma activity peaked during non-rapid eye movement sleep following the first administration and was maintained at high levels on all drug nights; (iii) beta activity increased through the night after administration of HAX and FNZ, but not TRI, which suggests a blood concentration level dependent increase of beta activity; and (iv) only HAX showed a residual effect on the fourth withdrawal night. These results indicate that (i) chronic administration of these three benzodiazepine derivatives produce similar profiles in sleep EEG spectral changes, with some differences depending on their half-lives and doses; (ii) the mechanism of sigma enhancement is sensitive to even the initial administration night of BDZ; and (iii) frequencies below and above the sigma band are less sensitive to BDZ and also show an increase through the night after administration, suggesting differences in the mechanisms reflected by these EEG frequency bands.

AB - The effects of 10 mg haloxazolam (HAX), 4 mg flunitrazepam (FNZ), and 0.5 mg triazolam (TRI), each administered for seven consecutive nights were studied in the sleep electroencephalograms (EEG) of 17 (six HAX, five FNZ and six TRI) healthy male student volunteers. Recordings of C3-A1 EEG data from one baseline night, three drug nights (first, fourth and seventh) and two withdrawal nights (second and fourth) were analyzed using a fast Fourier transformation method. All three drugs induced similar changes in the 0.5 Hz to 40 Hz power spectrum; namely (i) higher frequency (including the sigma and beta bands) activity increased and lower frequency activity reduced on the drug nights; (ii) the enhancement of sigma activity peaked during non-rapid eye movement sleep following the first administration and was maintained at high levels on all drug nights; (iii) beta activity increased through the night after administration of HAX and FNZ, but not TRI, which suggests a blood concentration level dependent increase of beta activity; and (iv) only HAX showed a residual effect on the fourth withdrawal night. These results indicate that (i) chronic administration of these three benzodiazepine derivatives produce similar profiles in sleep EEG spectral changes, with some differences depending on their half-lives and doses; (ii) the mechanism of sigma enhancement is sensitive to even the initial administration night of BDZ; and (iii) frequencies below and above the sigma band are less sensitive to BDZ and also show an increase through the night after administration, suggesting differences in the mechanisms reflected by these EEG frequency bands.

KW - Benzodiazepines

KW - Pharmacological potency

KW - Sleep electroencephalogram

KW - Spectral analysis

UR - http://www.scopus.com/inward/record.url?scp=0037324429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037324429&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1819.2003.01085.x

DO - 10.1046/j.1440-1819.2003.01085.x

M3 - Article

VL - 57

SP - 97

EP - 104

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 1

ER -